GAS6 and Autoimmunity: In general, TAM RTKs represent a promising target in autoimmunity as agonistic triggering of these receptors by overexpression of GAS6 has been shown to decrease disease severity in murine models of rheumatoid arthritis and multiple sclerosis33,34.